Clinical results of a phase 1 trial evaluating a HER2 directed CAR-T product selective for the tumor microenvironment (TME) in patients with GI and other solid tumor malignancies. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback